Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pharnext Makes New Appointments

This article was originally published in Scrip

Executive Summary

Neurologically focused Pharnext has appointed Niall Murphy chief scientific officer and Pierre Schwich chief financial officer (CFO). Schwich brings over 35 years of financial experience to the company and prior to joining Pharnext, he was CFO for Cellectis. Murphy is a professor at the department of psychiatry and biobehavioral sciences and a member of the brain research institute at the David Geffen School of Medicine at UCLA.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC064641

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel